ScreenerHero

MAGLEMagle Chemoswed Holding AB (publ)

STO · SE · Healthcare · Biotechnology · maglegroup.com
0.4200SEK+5.00%Mkt Cap: 829566 $P/E: —

Magle Chemoswed Holding AB (publ) engages in researching, developing, and manufacturing in the areas of medicinal chemistry and pharmaceutical technology in Sweden, Switzerland, rest of Europe, the United States, Brazil,…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap829.57K $
Enterprise Value33.49M $
Revenue (TTM)26.38M $
Gross Profit19.41M $
Net Income (TTM)-24.08M $
Revenue/Share1.281 USD
Last Price0.4200 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees150
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)0.17
PEG—
EV/EBITDA7.78
EV/Revenue1.27
P/S0.03
P/B0.03
EPS (TTM)-12.72
EPS (Forward)2.40
52W Range
0.39000% of range23.60
52W High23.60 SEK
52W Low0.3900 SEK
Profitability
Gross Margin75.74%
Oper. Margin-20.26%
EBITDA Margin16.33%
Profit Margin-93.95%
ROE-84.05%
ROA-30.66%
Growth
Revenue Growth39.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.60M $
CapEx (TTM)1.91M $
FCF Margin54.28%
FCF Yield1725.91%
Net Debt32.70M $
Net Debt/EBITDA7.59
Balance Sheet
Debt/Equity1.28
Current Ratio0.40
Quick Ratio0.19
Book Value/Sh13.55 SEK
Cash/Share0.1010 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1.000 SEK
Upside (mean)+138.1%
Target Range1.000 SEK – 1.000 SEK
# Analysts1
Ownership
Shares Out.20.65M
Float14.64M
Insiders27.42%
Institutions3.45%
Technical
SMA 500.8775 (-52.1%)
SMA 2007.857 (-94.7%)
Beta0.47
S&P 52W Chg18.16%
Avg Vol (30d)37.67K
Avg Vol (10d)13.53K
Technical Indicators
RSI (14)28.4
MACD-0.2164
MACD Signal-0.2496
MACD Hist.+0.0331
BB Upper0.9988 SEK
BB Middle0.5671 SEK
BB Lower0.1354 SEK
BB Width152.25%
ATR (14)0.0895 SEK
Vol Ratio (20d)0.66x